Albemarle: Strong Q2 Earnings, But Not A Buy Yet (NYSE:ALB)
· seekingalpha.com
Albemarle (ALB) beats Q2 2026 revenue/EPS, raises guidance and boosts free cash flow as lithium demand surges.
The specialty chemical company Albemarle Corporation ( ALB ) had their Q2 2026 earnings release on August 5th. If you’re not familiar with ALB, they are a glo...